Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. (0H8T)

Market Closed
12 Jun, 15:30
LSE LSE
$
4. 48
+0.33
+8.0362%
$
- Market Cap
- P/E Ratio
- Div Yield
2,278 Volume
-1.64 Eps
$ 4.14
Previous Close
Add Transaction
Day Range
4.26 4.48
Year Range
1.36 5.15
Want to track 0H8T and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Aclaris Therapeutics, Inc. logo
0H8T Aclaris Therapeutics, Inc.
6 May 2026
-
-
Aclaris Therapeutics, Inc. logo
0H8T Aclaris Therapeutics, Inc.
3 Mar 2026
-
-
Aclaris Therapeutics, Inc. logo
0H8T Aclaris Therapeutics, Inc.
6 Nov 2025
-
-
Aclaris Therapeutics, Inc. logo
0H8T Aclaris Therapeutics, Inc.
5 Aug 2025
-
-

0H8T Earnings Reports FAQ

What is the earnings per share (EPS) for 0H8T?

The current EPS is -1.64.

What is the company's earnings growth rate?

Aclaris Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Aclaris Therapeutics, Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Aclaris Therapeutics, Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 0H8T at this time, as Aclaris Therapeutics, Inc has no recent EPS data to calculate it.